CytoDyn will keep shareholders and stakeholders in

Quote:

---

CytoDyn will keep shareholders and stakeholders informed on the Company’s progress in implementing its leadership transition plan as and when appropriate.

---

Now might me the time to give us a damn clue. We went from a:

"webcast to discuss and provide updates with regard to NASH data results (350 and 700 mg), Cancer, COVID-19, HIV BLA, and finances of the Company on Thursday, January 13, 2022"

to absolutely no idea what the hell is going on, so CytoDyn, I feel you have a fiduciary obligation to give those of us who support you a PR.